Evidence map›Paper›PMID 31514484›Full record

ArticleGenes2019

Identifying Interaction Clusters for MiRNA and MRNA Pairs in TCGA Network.

Xinqing Dai, Lizhong Ding, Hannah Liu, Zesheng Xu, Hui Jiang, Samuel K Handelman, Yongsheng Bai

Abstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Characterization of tumor suppressors and oncogenes evaluated from TCGA cancers.American journal of clinical and experimental immunology · 2024
    Article
  3. Insight into NSCLC through novel analysis of gene interactions and characteristics.American journal of clinical and experimental immunology · 2024
    Article
  4. Article
  5. Article
  6. A holistic miRNA-mRNA module discovery.Non-coding RNA research · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinqing DaiDepartment of Mathematics and Computer Science, Indiana State University, Terre Haute, IN 47809, USA.
Lizhong DingDepartment of Biology, Indiana State University, Terre Haute, IN 47809, USA.
Hannah LiuCarmel High School, 520 E. Main St. Carmel, IN 46032, USA.
Zesheng XuSeven Lakes High School, 9251 S Fry Rd, Katy, TX 77494, USA.
Hui JiangDepartment of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
Samuel K HandelmanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Yongsheng BaiDepartment of Biology, Indiana State University, Terre Haute, IN 47809, USA. yongshengbaicool@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Existing methods often fail to recognize the conversions for the biological roles of the pairs of genes and microRNAs (miRNAs) between the tumor and normal samples. We have developed a novel cluster scoring method to identify messenger RNA (mRNA) and miRNA interaction pairs and clusters while considering tumor and normal samples jointly. Our method has identified 54 significant clusters for 15 cancer types selected from The Cancer Genome Atlas project. We also determined the shared clusters across tumor types and/or subtypes. In addition, we compared gene and miRNA overlap between lists identified in our liver hepatocellular carcinoma (LIHC) study and regulatory relationships reported from human and rat nonalcoholic fatty liver disease studies (NAFLD). Finally, we analyzed biological functions for the single significant cluster in LIHC and uncovered a significantly enriched pathway (phospholipase D signaling pathway) with six genes represented in the cluster, symbols:

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksAlgorithmsCarcinoma, HepatocellularGenome, HumanGenomicsGuanine Nucleotide Exchange FactorsHumansLiver NeoplasmsMicroRNAsPhosphatidylinositol 3-KinasesReceptor, Platelet-Derived Growth Factor betaReceptors, Lysophosphatidic AcidReceptors, ProstaglandinRNA, MessengerGuanine Nucleotide Exchange FactorsLPAR2 protein, humanMicroRNAsPDGFRB protein, humanPhosphatidylinositol 3-KinasesPIK3R3 protein, humanprostaglandin F2alpha receptorRAPGEF3 protein, humanReceptor, Platelet-Derived Growth Factor betaReceptors, Lysophosphatidic AcidReceptors, ProstaglandinRNA, Messengerclustering algorithmgene regulationliver hepatocellular carcinomamiRNAmRNAThe Cancer Genome Atlas

Identifiers

PMID31514484
PMCPMC6770970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.